Find out in less than 5 minutes if you qualify to file a Zantac Cancer Claim.N-Nitrosodimethylamine (NDMA) is a yellow liquid with little to no odor and is classified as a B2 carcinogen, which means it is known to be a probable cause of cancer in humans. It is also found all around us. NDMA […]
Continue readingBy Justin Groen
Let’s start with the obvious: no doctor wakes up in the morning and thinks to themselves, “I would like to prescribe a known carcinogen to one of my patients today.” BUT – if your doctor is currently prescribing you Zantac or ranitidine to treat your acid reflux, GERD, or other heartburn related ailments, then that […]
Continue reading
Ever since the end of 2019, Zantac has been in the news pretty frequently. First for warnings, then voluntary recalls, than an offical Zantac recall by the FDA, and now because of a growing multi-district litigation in Florida on behalf of hundreds of victims who took the drug and were later diagnosed with cancer. But […]
Continue reading
If you’ve watched the news at all recently, you’ve likely heard about the Zantac Recall. Zantac, a very common and now recalled antacid medication, is now considered dangerous to humans because it is linked to a dangerous chemical impurity known as NDMA (N-Nitroso-dimethylamine). Zantac Recall: What is NDMA? NDMA is a yellow liquid which has […]
Continue readingBy Joe Messa
Firm Founder, Joseph Messa, recently appeared on “Saturday Night Live with Philly Labor Radio,” a weekly talk-radio show that “airs every Saturday Evening at 7pm on TALK RADIO 1210 WPHT and presents an insider’s look at the Philadelphia area labor movement.” On the program, Attorney Messa discussed a range of topics, from how the firm […]
Continue readingBy Angela Leone
From our Founder, Joseph L. Messa, Jr. – First, I hope you and your loved ones are safe and well. In this uncertain and unprecedented time, it is so important to remain focused on self-care and to abide by the guidelines set forth by the CDC and our State Government leaders. It is difficult and […]
Continue readingBy Joe Messa
The U.S. Food and Drug Administration (FDA) issued a press release today requesting that manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This comes months after the FDA announced its initial warning regarding ranitidine medications (brand name ZANTAC) and the possible presence of a contaminant known as N-Nitrosodimethylamine (NDMA). NDMA […]
Continue readingBy Angela Leone
Tragedy struck in Southwest Philly last Friday after a fire broke out in a Bonnaffon Street row home, claiming the lives of a 40-year-old woman and her 4-year-old and 1-year-old grandsons. Firefighters arrived at the 2000 block of Bonnaffon Street just after 6:30pm on Friday, March 27th to heavy flames emerging from second story windows. […]
Continue readingBy Angela Leone
Earlier this month, IKEA issued a recall of nearly one million KULLEN 3-drawer dressers for posing tip-over and entrapment hazards. The recall came after numerous reports of furniture tip-over incidents that resulted in minor injuries to consumers. About a month-or-so before that recall, the Swedish furniture retailer agreed to pay $46M to settle a wrongful […]
Continue reading